Cambridge Investment Research Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 53,536 shares of TEVA stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,536
Previous 53,256
0.53%
Holding current value
$1.22 Million
Previous $865,000
11.56%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding TEVA
# of Institutions
625Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$979 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$825 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$787 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$657 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$603 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $25.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...